{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T20:48:19Z","timestamp":1791146899899,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2009,2,13]],"date-time":"2009-02-13T00:00:00Z","timestamp":1234483200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1007\/s00330-009-1303-z","type":"journal-article","created":{"date-parts":[[2009,2,12]],"date-time":"2009-02-12T16:56:11Z","timestamp":1234457771000},"page":"1347-1357","source":"Crossref","is-referenced-by-count":71,"title":["The role of 18F-FDG PET\/CT in evaluation of early response to neoadjuvant chemotherapy in patients with locally advanced breast cancer"],"prefix":"10.1007","volume":"19","author":[{"given":"Amandeep","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vathalaru","family":"Seenu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sidharatha Datta","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhavi","family":"Chawla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun","family":"Malhotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sada Nand","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,2,13]]},"reference":[{"key":"1303_CR1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/cncr.20288","volume":"101","author":"A Jemal","year":"2004","unstructured":"Jemal A, Clegg LX, Ward E et al (2004) Annual report to the nation on the status of cancer, 1975\u20132001, with a special feature regarding survival. Cancer 101:3\u201327","journal-title":"Cancer"},{"issue":"3","key":"1303_CR2","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/annonc\/mdl498","volume":"18","author":"J Ferlay","year":"2007","unstructured":"Ferlay J, Autier P, Boniol M et al (2007) Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 18(3):581\u2013592","journal-title":"Ann Oncol"},{"key":"1303_CR3","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1097\/00000658-194212000-00002","volume":"116","author":"CD Haagensen","year":"1942","unstructured":"Haagensen CD, Stout AP (1942) Carcinoma of the breast: I. Results of treatment. Ann Surg 116:801\u2013815","journal-title":"Ann Surg"},{"key":"1303_CR4","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1097\/00000658-194311850-00008","volume":"118","author":"CD Haagensen","year":"1943","unstructured":"Haagensen CD, Stout AP (1943) Carcinoma of the Breast: II. Criteria of operability. Ann Surg 118:859\u2013870 1032\u201351","journal-title":"Ann Surg"},{"key":"1303_CR5","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3322\/canjclin.45.4.227","volume":"45","author":"G Bonadonna","year":"1995","unstructured":"Bonadonna G, Valagussa P, Zucali R et al (1995) Primary chemotherapy in surgically resectable breast cancer. CA Cancer J Clin 45:227\u2013243","journal-title":"CA Cancer J Clin"},{"key":"1303_CR6","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/(SICI)1098-2388(199601\/02)12:1<59::AID-SSU9>3.0.CO;2-5","volume":"12","author":"H Wang","year":"1996","unstructured":"Wang H, Lo S (1996) Future prospects of neoadjuvant chemotherapy in treatment of primary breast cancer. Semin Surg Oncol 12:59\u201366","journal-title":"Semin Surg Oncol"},{"key":"1303_CR7","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/S0959-8049(05)80161-3","volume":"29A","author":"M Clavel","year":"1993","unstructured":"Clavel M, Catimel G (1993) Breast cancer: Chemotherapy in the treatment of advanced disease. Eur J Cancer 29A:598\u2013604","journal-title":"Eur J Cancer"},{"key":"1303_CR8","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1200\/JCO.1997.15.7.2483","volume":"15","author":"B Fisher","year":"1997","unstructured":"Fisher B, Brown A, Mamounas E et al (1997) Effect of preoperative chemotherapy on loco-regional disease in women with operable breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-18. J Clin Oncol 15:2483\u20132493","journal-title":"J Clin Oncol"},{"key":"1303_CR9","first-page":"493","volume":"179","author":"SD Heys","year":"1994","unstructured":"Heys SD, Eremin JM, Sarkar TK et al (1994) Role of multimodality therapy in the management of locally advanced carcinoma of the breast. J Am Coll Surg 179:493\u2013504","journal-title":"J Am Coll Surg"},{"key":"1303_CR10","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/0002-9343(80)90472-6","volume":"69","author":"E Frei III","year":"1980","unstructured":"Frei E III, Canellos GP (1980) Dose, a critical factor in cancer chemotherapy. Am J Med 69:585\u2013594","journal-title":"Am J Med"},{"key":"1303_CR11","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","volume":"47","author":"AB Miller","year":"1981","unstructured":"Miller AB, Hoogstraten B, Staquet M, Winkler A (1981) Reporting results of cancer treatment. Cancer 47:207\u2013214","journal-title":"Cancer"},{"key":"1303_CR12","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","volume":"92","author":"P Therasse","year":"2000","unstructured":"Therasse P, Arbuck SG, Eisenhauer EA et al (2000) New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst 92:205\u2013216","journal-title":"J Natl Cancer Inst"},{"key":"1303_CR13","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1016\/0959-8049(95)00421-1","volume":"31A","author":"P Price","year":"1995","unstructured":"Price P, Jones T (1995) Can Positron Emission Tomography be used to assess subclinical response to cancer therapy? The EC PET Oncology Concerted action and the EORTC PET study. Eur J Cancer 31A:1924\u20131927","journal-title":"Eur J Cancer"},{"key":"1303_CR14","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1200\/JCO.1993.11.11.2101","volume":"11","author":"RL Wahl","year":"1993","unstructured":"Wahl RL, Zasadny K, Helvie M, Hutchins GD, Weber B, Cody R (1993) Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: initial evaluation. J Clin Oncol 11:2101\u20132111","journal-title":"J Clin Oncol"},{"key":"1303_CR15","first-page":"931","volume":"37","author":"P Bassa","year":"1996","unstructured":"Bassa P, Kim E, Inoue T et al (1996) Evaluation of preoperative chemotherapy using PET with Fluorine-18 fluorodeoxyglucose in breast cancer. J Nucl Med 37:931\u2013938","journal-title":"J Nucl Med"},{"key":"1303_CR16","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1200\/JCO.2000.18.8.1689","volume":"18","author":"M Schelling","year":"2000","unstructured":"Schelling M, Avril N, Nahrig J et al (2000) Positron emission tomography using [18F]fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer. J Clin Oncol 18:1689\u20131695","journal-title":"J Clin Oncol"},{"key":"1303_CR17","doi-asserted-by":"crossref","first-page":"5366","DOI":"10.1200\/JCO.2006.05.7406","volume":"24","author":"C Rousseau","year":"2006","unstructured":"Rousseau C, Devillers A, Sagan C, Ferrer L, Bridji B, Campion L (2006) Monitoring of early response to neoadjuvant chemotherapy in stage II and III breast cancer by [18F]fluorodeoxyglucose positron emission tomography. J Clin Oncol 24:5366\u20135372","journal-title":"J Clin Oncol"},{"key":"1303_CR18","first-page":"297","volume":"180","author":"DM Sataloff","year":"1995","unstructured":"Sataloff DM, Mason BA, Prestipino AJ et al (1995) Pathologic response to induction chemotherapy in locally advanced carcinoma of the breast: A determinant of outcome. J Am Coll Surg 180:297\u2013306","journal-title":"J Am Coll Surg"},{"key":"1303_CR19","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1200\/JCO.2000.18.8.1676","volume":"18","author":"IC Smith","year":"2000","unstructured":"Smith IC, Welch AE, Hutcheon AW et al (2000) Positron emission tomography using (18F)-fluorodeoxy-D-glucose to predict the pathologic response of breast cancer to primary chemotherapy. J Clin Oncol 18:1676\u20131688","journal-title":"J Clin Oncol"},{"key":"1303_CR20","first-page":"931","volume":"13","author":"T Jansson","year":"1996","unstructured":"Jansson T, Westlin JE, Ahlstrom H et al (1996) Positron emission tomography studies in patients with locally advanced and\/or metastatic breast cancer: a method for early therapy evaluation? J Nucl Med 13:931\u2013938","journal-title":"J Nucl Med"},{"key":"1303_CR21","first-page":"1806","volume":"44","author":"DA Mankoff","year":"2003","unstructured":"Mankoff DA, Dunnwald LK, Gralow JR et al (2003) Changes in blood flow and metabolism in locally advanced breast cancer treated with neoadjuvant chemotherapy. J Nucl Med 44:1806\u20131814","journal-title":"J Nucl Med"},{"key":"1303_CR22","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S0748-7983(95)91492-7","volume":"21","author":"DM Bruce","year":"1995","unstructured":"Bruce DM, Evans NT, Heys SD et al (1995) Positron emission tomography: 2-deoxy-2 [18F]-fluoro-D-glucose uptake in locally advanced breast cancers. Eur J Surg Oncol 21:280\u2013283","journal-title":"Eur J Surg Oncol"},{"key":"1303_CR23","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s002590100539","volume":"28","author":"R Tiling","year":"2001","unstructured":"Tiling R, Linke R, Untch M et al (2001) 18F-FDG PET and 99mTcsestamibi scintimammography for monitoring breast cancer response to neoadjuvant chemotherapy: a comparative study. Eur J Nucl Med 28:711\u2013720","journal-title":"Eur J Nucl Med"},{"key":"1303_CR24","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1093\/annonc\/mdh345","volume":"15","author":"SJ Kim","year":"2004","unstructured":"Kim SJ, Kim SK, Lee ES, Ro J, Kang SH (2004) Predictive value of [18F] FDG PET for pathological response of breast cancer to neo-adjuvant chemotherapy. Ann of Oncol 15:1352\u20131357","journal-title":"Ann of Oncol"},{"key":"1303_CR25","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s11307-005-0029-9","volume":"8","author":"BS Pio","year":"2006","unstructured":"Pio BS, Park CK, Pietras R et al (2006) Usefulness of 3\u2032-[F-18] fluoro-3\u2032-deoxythymidine with positron emission tomography in predicting breast cancer response to therapy. Mol Imaging Biol 8:36\u201342","journal-title":"Mol Imaging Biol"},{"issue":"9","key":"1303_CR26","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1007\/s00259-007-0379-4","volume":"34","author":"L Kenny","year":"2007","unstructured":"Kenny L, Coombes RC, Vigushin DM, Al-Nahhas A, Shousha S, Aboagye EO (2007) Imaging early changes in proliferation at 1 week post chemotherapy: a pilot study in breast cancer patients with 3\u2032-deoxy-3\u2032-[18F]fluorothymidine positron emission tomography. Eur J Nucl Med Mol Imaging 34(9):1339\u20131347","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"1303_CR27","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s10549-006-9316-7","volume":"102","author":"GM McDermott","year":"2007","unstructured":"McDermott GM, Welch A, Staff RT et al (2007) Monitoring primary breast cancer throughout chemotherapy using FDG-PET. Breast Cancer Res Treat 102(1):75\u201384","journal-title":"Breast Cancer Res Treat"},{"key":"1303_CR28","first-page":"1442","volume":"6","author":"D Li","year":"2007","unstructured":"Li D, Yao Q, Li L, Wang L, Chen J (2007) Correlation between hybrid 18F-FDG PET\/CT and apoptosis induced by neoadjuvant chemotherapy in breast cancer. Cancer Biol Ther 6:1442\u20131448","journal-title":"Cancer Biol Ther"},{"issue":"2","key":"1303_CR29","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1148\/radiol.2332031285","volume":"233","author":"S Meisamy","year":"2004","unstructured":"Meisamy S, Bolan PJ, Baker EH et al (2004) Neoadjuvant chemotherapy of locally advanced breast cancer: predicting response with in vivo (1)H MR spectroscopy\u2014 a pilot study at 4 T. Radiology 233(2):424\u2013431","journal-title":"Radiology"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-009-1303-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00330-009-1303-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-009-1303-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T11:54:40Z","timestamp":1559044480000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00330-009-1303-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2,13]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["1303"],"URL":"https:\/\/doi.org\/10.1007\/s00330-009-1303-z","relation":{},"ISSN":["0938-7994","1432-1084"],"issn-type":[{"value":"0938-7994","type":"print"},{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2,13]]}}}